Fortis Healthcare Limited (NSE:FORTIS)
India · Delayed Price · Currency is INR | Market Cap | 548.59B -33.8% |
| Revenue (ttm) | 95.06B +17.5% |
| Net Income | 10.48B +20.7% |
| EPS | 13.88 +20.6% |
| Shares Out | 754.96M |
| PE Ratio | 52.36 |
| Forward PE | 40.69 |
| Dividend | 1.00 (0.14%) |
| Ex-Dividend Date | Jul 24, 2026 |
| Volume | 1,275,404 |
| Open | 723.50 |
| Previous Close | 729.00 |
| Day's Range | 710.80 - 726.65 |
| 52-Week Range | 710.80 - 1,104.00 |
| Beta | 0.64 |
| Analysts | Strong Buy |
| Price Target | 1,098.25 (+51.14%) |
| Est. Earnings | Nov 13, 2026 |
About Fortis Healthcare
Fortis Healthcare Limited operates as a healthcare delivery service provider in India. The company services in the areas of cardiac science, nephrology, diabetology/endocrinology, foetal medicine, infectious diseases, mental health and behavioral science, oncology, orthopedics, physiotherapy and rehabilitation, rheumatology, urology, nuclear medicine, critical care, emergency and trauma, general surgery, internal medicine, neurointerventional radiology, obstetrics and gynaecology, pediatrics, pediatrics, vascular surgery, and support facilities... [Read more]
Financial Performance
In fiscal year 2026, Fortis Healthcare's revenue was 91.28 billion, an increase of 17.28% compared to the previous year's 77.83 billion. Earnings were 10.42 billion, an increase of 34.56%.
Financial StatementsAnalyst Summary
According to 20 analysts, the average rating for FORTIS stock is "Strong Buy." The 12-month stock price target is ₹1,098, which is an increase of 51.14% from the latest price.
News
Supreme Court allows forensic audit in Fortis case
NEW DELHI: The Supreme Court on Tuesday upheld a Delhi HC order directing forensic audit of dissipation of shares of Fortis Healthcare Ltd (FHL) and
India's top court disposes of Fortis' petition against IHH Healthcare unit
Malaysia's IHH Healthcare said on Monday that India's top court has disposed of Fortis Healthcare's petition challenging a court-ordered forensic audit relating to a stake purchase by an IHH Healthcar...
Malaysia's IHH's unit appeals Tokyo court's rejection of Daiichi Sankyo damages claim
Malaysia's IHH Healthcare said on Thursday its subsidiary has appealed a Tokyo court's dismissal of its damages claim against Daiichi Sankyo over the unit's acquisition of a stake in India's Fortis He...
Fortis investors flag legal overhang after Delhi HC order
Domestic and foreign institutional investors of Fortis Healthcare (Fortis) have expressed concern that the Delhi High Court’s order seeking a forensic audit of transactions involving its former promot...
Fortis moves Supreme Court against Delhi High Court order
Fortis Healthcare has appealed to the Supreme Court against a recent Delhi High Court order. The order mandated a forensic audit of Fortis's dealings with IHH Healthcare and RHT Health Trust. This leg...
Malaysia's IHH's unit loses Tokyo court case against Daiichi Sankyo over Fortis deal
Malaysia's IHH Healthcare said on Thursday that a Tokyo court has dismissed its unit's damage claims against Japan's Daiichi Sankyo tied to its 2018 acquisition of a stake in India's Fortis Healthcare...
Fortis Healthcare Transcript: Investor update
The Delhi High Court has ordered a forensic audit into past transactions, including IHH’s investment and RHT asset acquisition, but this does not affect ongoing operations, growth plans, or capital infusions. Both management and IHH remain confident in compliance and foresee no material adverse impact.
Indian court directs forensic auditor appointment in Daiichi-Fortis case, IHH says
Malaysia's IHH Healthcare said on Tuesday that an Indian court directed the appointment of a forensic auditor in relation to certain applications filed by Japan's Daiichi Sankyo against Fortis Healthc...
Fortis Healthcare Transcript: Q1 26/27
Q1 FY27 saw 17.5% revenue growth and steady margins, with strong hospital and diagnostics performance. Margin guidance of 25% by FY28 is maintained despite ESOP costs, supported by expansion and operational improvements. Oncology growth slowed due to pricing changes.
Fortis Healthcare Quarterly report: Q1 2027
Fortis Healthcare has published its Q1 2027 quarterly earnings report on August 7, 2026.
Fortis Healthcare Slides: Q1 2027
Fortis Healthcare has posted slides in relation to its Q1 2027 quarterly earnings report, which was published on August 7, 2026.
Fortis Healthcare signs agreement for 300-bed hospital in Odisha
Fortis Healthcare has entered into an Operations and Management (O&M) agreement with Dion Group to establish a 300-bed multi-specialty hospital in Cuttack, Odisha. This strategic partnership aims to b...
Fortis Healthcare shares in focus as Delhi government orders action against its Shalimar Bagh hospital
Shares of Fortis Healthcare are in focus after the Delhi government ordered action against its Shalimar Bagh hospital following the death of a patient. The development comes after Delhi Chief…
Fortis Healthcare tax demand reduced to ₹61.48 crore for AY 2024-25
Fortis Healthcare Limited has announced a significant reduction in the tax demand raised by the Income Tax Authority against its wholly-owned subsidiary, Fortis Hospitals Limited. The demand has been ...
Top stocks to buy or sell today: Stock market recommendations for June 9, 2026 - check list
Stock market recommendations: Kalyan Jewellers India, and Interglobe Aviation (IndiGo) are sell calls by Somil Mehta, Head of Retail Research at Mirae Asset ShareKhan for June 9, 2026. He recommends b...
Fortis Healthcare processes 736 physical share transfer requests in March 2026
Fortis Healthcare has processed a total of 736 requests for the re-lodgement of physical share transfers during March 2026, as per a report from its Registrar and Share Transfer Agent,…
Fortis Healthcare announces appointment of new Chief Financial Officer
Fortis Healthcare has announced the appointment of a new Chief Financial Officer (CFO), effective immediately. The company has named Mr. Rajesh Gopinathan as the new CFO, bringing with him a…
Fortis Healthcare reports ₹1 final dividend per share for FY 2025-26
Fortis Healthcare Limited has announced a final dividend of ₹1 per equity share for the financial year 2025-26, subject to the approval of the company's members. The dividend, which represents…
Fortis Healthcare announces ₹1 per share dividend for FY 2025-26
Fortis Healthcare Limited has declared a final dividend of ₹1 per equity share for the financial year 2025-26, representing 10% of the face value of ₹10 per share. This decision,…
Fortis Healthcare Q4 Results: Net profit jumps 45% YoY to Rs 266 crore, EBITDA margin improves
Fortis Healthcare reported a strong performance for the fourth quarter of FY26, with healthy growth in profit, revenue, and operating margins on a year-on-year basis. The hospital chain continued to…
Fortis Healthcare reports 44.2% rise in Q4 FY26 profit after tax to ₹271 crore
Fortis Healthcare, a prominent player in India's healthcare sector, has announced a significant increase in its financial performance for the fourth quarter and full financial year ending March 31, 20...
Fortis Healthcare Transcript: Q4 25/26
Strong revenue and profit growth in FY 2026 driven by hospital and diagnostic segments, with robust expansion plans and margin improvement guidance for FY 2027. Strategic investments, new bed additions, and focus on clinical quality position the business for sustained growth.
Fortis Healthcare Quarterly report: Q4 2026
Fortis Healthcare has published its Q4 2026 quarterly earnings report on May 22, 2026.
Fortis Healthcare Slides: Q4 2026
Fortis Healthcare has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 22, 2026.
Fortis Healthcare Annual report: Q4 2026
Fortis Healthcare has published its Q4 2026 annual report on May 22, 2026.